Cure My Disease

Don't miss your cure!

 Log in / Sign up

Scientists hunt for clues in breast cancer tissue to predict relapse

NCT ID NCT02050750

Ongoing Knowledge-focused Sponsor: Cancer Trials Ireland Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study collects and stores breast cancer tissue from 600 people who took part in the TAILORx trial. Researchers will analyze the samples to find biological markers that can predict if the cancer will come back or resist hormone therapy and chemotherapy. No new treatments are given; the goal is to better understand the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

  • Adelaide and Meath National Children's Hospital Tallaght

    Dublin, 24, Ireland

  • Beaumont Hospital

    Dublin, 9, Ireland

  • Bons Secours Hospital

    Cork, Ireland

  • Cork University Hospital

    Cork, Ireland

  • Galway University Hospital

    Galway, Ireland

  • Letterkenny General Hospital

    Donegal, Ireland

  • Mater Misericordiae University Hospital

    Dublin, Ireland

  • Midwestern Regional Hospital

    Limerick, Ireland

  • Sligo General Hosptial

    Sligo, Ireland

  • St James Hospital

    Dublin, 8, Ireland

  • St Vincent Universtiy Hospital

    Dublin, 4, Ireland

  • Waterford Regional Hospital

    Waterford, Ireland

More trials for these conditions

Other studies related to the condition(s) this trial covers.